{"id":"1ddd3749-3f47-4b40-a33c-85e753cb100a","modelId":"11d93de0-ecbc-40c1-9cbf-78faec650556","versionId":null,"locationId":"192edfdf-fa70-4354-a507-c8728ecde78b","operatorId":null,"ownerId":null,"slug":"sapien-3-transcatheter-heart-valve-los-angeles-california-usa","status":"operational","firstSeen":"2019-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.121.010543","name":"Circulation: Cardiovascular Interventions","title":"Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve"}],"notes":"Cedars-Sinai Medical Center, Los Angeles, is listed as a site in real-world SAPIEN 3 Ultra experience studies. Raj Makkar, MD is a key investigator.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T22:33:28.079Z","updatedAt":"2026-08-09T04:18:13.319Z","model":{"id":"11d93de0-ecbc-40c1-9cbf-78faec650556","companyId":"311e9cc4-68db-4d74-b74c-33fd30682fc4","modelName":"SAPIEN 3 Transcatheter Heart Valve","slug":"sapien-3-transcatheter-heart-valve","description":"The SAPIEN 3 is a transcatheter aortic heart valve system used for TAVR (transcatheter aortic valve replacement) to treat severe aortic stenosis without open-heart surgery. FDA-approved for low-risk patients since August 2019, and approved for asymptomatic patients in May 2025. Includes SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA variants.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Edwards_Lifesciences","title":"Edwards Lifesciences - Wikipedia","sourceName":"Wikipedia"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"S&P 500 Component","value":"Yes"},{"label":"Key Product","value":"Cordella Pulmonary Artery Sensor (FDA-approved June 2024 for heart failure management)"},{"label":"Manufacturing","value":"Irvine CA, Draper UT, Costa Rica, Singapore, Limerick Ireland, Moncada Spain (under construction)"}],"createdAt":"2026-07-07T11:06:51.948Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"311e9cc4-68db-4d74-b74c-33fd30682fc4","name":"Edwards Lifesciences","slug":"edwards-lifesciences","description":"Edwards Lifesciences is an American medical technology company headquartered in [Irvine, California](https://en.wikipedia.org/wiki/Irvine,_California), specializing in tissue heart valves and transcatheter technologies for structural heart disease. Founded by Miles Lowell Edwards in 1958, the company invented the first successful artificial heart valve (the Starr-Edwards valve) and pioneered transcatheter aortic valve replacement (TAVR) with its [SAPIEN 3](https://www.edwards.com) platform. The company is listed on the NYSE (EW) and is an S&P 500 component.","status":"active","founded":1958,"hq":"Irvine, California, USA","hqLat":33.6856969,"hqLng":-117.825981,"hqGeocodedAt":"2026-08-05T14:27:55.168Z","hqAddress":null,"hqPrecision":null,"website":"edwards.com","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.edwards.com/","title":"Edwards","date_accessed":"2026-06-07"}],"keyFacts":[{"label":"CEO","value":"Bernard J. Zovighian"},{"label":"Previous CEO","value":"Michael Mussallem (2000-2023, founder-era leader who took company public)"},{"label":"Founder","value":"Miles Lowell Edwards (electrical engineer, invented first artificial heart valve)"},{"label":"NYSE Ticker","value":"EW"},{"label":"S&P 500 Component","value":"Yes"},{"label":"Key Product","value":"Cordella Pulmonary Artery Sensor (FDA-approved June 2024 for heart failure management)"},{"label":"Manufacturing","value":"Irvine CA, Draper UT, Costa Rica, Singapore, Limerick Ireland, Moncada Spain (under construction)"},{"label":"Parent Company History","value":"Acquired by Baxter International 1985, spun off in 2000 IPO"},{"label":"Revenue 2025","value":"US.07 billion"},{"label":"Employees","value":"16,000 (2025)"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"EW","stockExchange":"NYSE","secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":16000,"employeeCountBasis":"reported","employeeCountAsOf":"2025-12-31T12:00:00.000Z","marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-08T04:27:19.214Z","updatedAt":"2026-08-05T14:39:49.258Z"}},"version":null,"location":{"id":"192edfdf-fa70-4354-a507-c8728ecde78b","name":"Cedars-Sinai Medical Center","slug":"los-angeles-california-usa","kind":"hospital","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-08T22:32:59.612Z","updatedAt":"2026-08-09T04:26:19.821Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/sapien-3-transcatheter-heart-valve-los-angeles-california-usa","url":"https://registry.deploy.report/deployments/sapien-3-transcatheter-heart-valve-los-angeles-california-usa","name":"SAPIEN 3 Transcatheter Heart Valve at Cedars-Sinai Medical Center","identifier":"1ddd3749-3f47-4b40-a33c-85e753cb100a","startDate":"2019-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/los-angeles-california-usa","name":"Cedars-Sinai Medical Center"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/edwards-lifesciences","name":"Edwards Lifesciences"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/sapien-3-transcatheter-heart-valve","name":"SAPIEN 3 Transcatheter Heart Valve"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}